Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with relapse within 2 years of inpatient treatment among men with alcohol dependence syndrome.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2026
Same author

Do Nanobubbles Exist in Pure Alcohol?

Langmuir : the ACS journal of surfaces and colloids·2024
Same author

On Nanobubble Dynamics under an Oscillating Pressure Field during Salting-out Effects and Its DLVO Potential.

Langmuir : the ACS journal of surfaces and colloids·2023
Same author

Ion transport and current rectification in a charged conical nanopore filled with viscoelastic fluids.

Scientific reports·2022
Same author

Does salting-out effect nucleate nanobubbles in water: Spontaneous nucleation?

Ultrasonics sonochemistry·2021
Same author

Cognitive dysfunction in patients with renal failure requiring hemodialysis.

Indian journal of psychological medicine·2013

Related Experiment Videos

Risperidone mono - therapy as prophylaxis in bipolar affective disorders.

Mohit Trivedi1, Denzil Pinto, A T Safeekh

  • 1P.G. Resident, Dept. of Psychiatry, Father Muller Medical College, Kankanady, Mangalore - 575 002.

Indian Journal of Psychiatry
|January 13, 2011
PubMed
Summary

Risperidone monotherapy effectively prevented bipolar affective disorder (BPAD) relapses in this case report. This highlights its potential role in long-term BPAD management and prophylaxis.

Keywords:
BPADprophylaxisrisperidone

Related Experiment Videos

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Bipolar affective disorder (BPAD) is a chronic mental health condition characterized by mood swings.
  • Acute phases of BPAD often require pharmacological intervention.
  • Long-term management strategies, including prophylaxis, are crucial for patient well-being.

Purpose of the Study:

  • To present a case report on the efficacy of risperidone monotherapy.
  • To evaluate risperidone's role in the prophylaxis of bipolar affective disorder.
  • To discuss the pharmacological and clinical implications of using risperidone for BPAD management.

Main Methods:

  • Case report methodology.
  • Utilized risperidone as a single agent (monotherapy).
  • Monitored patient for prophylactic effects against bipolar affective disorder episodes.

Main Results:

  • Risperidone monotherapy demonstrated effectiveness in preventing bipolar affective disorder relapses.
  • The treatment was well-tolerated, suggesting a favorable safety profile for prophylaxis.
  • Case findings support the utility of risperidone beyond acute treatment.

Conclusions:

  • Risperidone monotherapy can be an effective strategy for the prophylaxis of bipolar affective disorder.
  • The findings warrant further investigation into risperidone's long-term prophylactic potential in BPAD.
  • Pharmacological and clinical implications suggest a broader role for risperidone in BPAD management.